S&P 500 Industrials Sector SEC Filings — February 17, 2026

18-02-2026

FRESH DEL MONTE PRODUCE INC filed an 8-K on 2026-02-18 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, period-over-period changes, or other metrics are disclosed in the provided filing details. This is an informational disclosure typical for earnings releases.

18-02-2026

urban-gro, Inc. filed a Form 8-K on 2026-02-18 reporting entry into a Material Definitive Agreement under Item 1.01, Regulation FD Disclosure under Item 7.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement's nature, counterparties, financial terms, or impacts provided. No revenue, earnings, balance sheet effects, guidance changes, or other quantitative metrics are disclosed.

• ·File size: 1 MB
• ·Accession Number: 0001213900-26-017587
• ·Sector: NOT_DISCLOSED

18-02-2026

SolarEdge Technologies, Inc. filed a Form 8-K on 2026-02-18 reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a standard earnings-related disclosure. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

• ·AccNo: 0001178913-26-000558
• ·Filing size: 1 MB

18-02-2026

NewAmsterdam Pharma Co N.V. filed a Form 8-K on February 18, 2026 (AccNo: 0001193125-26-056020), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative financial metrics are available for analysis.

18-02-2026

Avis Budget Group, Inc. filed an 8-K on February 18, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing information. This appears to be a standard voluntary earnings announcement filing.

18-02-2026

Bridgeline Digital, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001437749-26-004457, Size: 366 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This constitutes a multi-item filing for financial results announcement. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data are disclosed in the provided filing information.

18-02-2026

Gladstone Investment Corporation filed an 8-K on February 18, 2026, under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 reporting the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are disclosed.

18-02-2026

OGE Energy Corp. filed a Form 8-K on February 18, 2026 (AccNo: 0001193125-26-055417), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific financial metrics, revenue, earnings, period-over-period changes, guidance, or other quantitative data are disclosed in the provided filing information. This represents a standard earnings-related disclosure without detailed performance indicators.

18-02-2026

Hormel Foods Corp /DE/ filed a Form 8-K on February 18, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard disclosure for financial results with no detailed quantitative data available.

18-02-2026

GLOBAL PAYMENTS INC filed an 8-K on 2026-02-18 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including position, appointment or resignation, reasons, financial metrics, or performance comparisons are NOT_DISCLOSED.

18-02-2026

Moody's Corp /DE/ filed an 8-K on February 18, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

18-02-2026

Philip Morris International Inc. filed an 8-K on February 18, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary provided. Critical details on the content of the Regulation FD disclosure are missing.

18-02-2026

Bausch & Lomb Corp filed a Form 8-K on 2026-02-18 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics were mentioned in the filing details provided. This appears to be a standard mandatory earnings-related disclosure without quantified performance data available.

18-02-2026

Analog Devices Inc filed an 8-K on February 18, 2026 (AccNo: 0000006281-26-000015), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or quantitative metrics are detailed in the provided information. No positive or negative performance indicators, period-over-period comparisons, or transaction values were mentioned.

18-02-2026

Madison Square Garden Sports Corp. filed an 8-K on February 18, 2026 (AccNo: 0001193125-26-056081, Size: 137 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected position, individuals involved, reasons for the change, or any quantitative metrics are disclosed. No positive or negative impacts are specified, resulting in neutral informational disclosure.

18-02-2026

Tarsus Pharmaceuticals, Inc. disclosed an officer change via 8-K filing on February 18, 2026, under Item 5.02 covering departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or terms are disclosed.

18-02-2026

Liberty Global Ltd. filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information. No positive or negative performance details are available.

18-02-2026

Health Catalyst, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation, reasons, or any quantitative metrics are provided. No positive or negative performance metrics, changes, or scheduled events are mentioned.

18-02-2026

M Evo Global Acquisition Corp II filed an 8-K on 2026-02-18 disclosing other events under Item 8.01 in the context of a merger/acquisition, with Item 9.01 providing financial statements and exhibits. No specific deal structure, parties, financial metrics, or impacts are disclosed. No positive or negative metrics are present.

18-02-2026

Heritage Distilling Holding Company, Inc. filed a Form 8-K on February 18, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, alongside Regulation FD Disclosure under Item 7.01. Item 9.01 includes financial statements and exhibits. No specific details, quantitative impacts, positive or negative metrics, or dollar values are disclosed in the filing summary.

18-02-2026

Washington Trust Bancorp Inc filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or compensatory arrangements are disclosed in the provided information. No quantitative financial metrics, performance comparisons, or other material data points are mentioned.

• ·AccNo: 0000737468-26-000031
• ·File Size: 165 KB
• ·Sector: not specified

18-02-2026

eBay Inc filed an 8-K on February 18, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no detailed quantitative data available.

18-02-2026

FB Bancorp, Inc. (/MD/) filed a Form 8-K on February 18, 2026 (AccNo: 0001193125-26-057030), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are provided in the filing details.

18-02-2026

CENTRAL GARDEN & PET CO filed an 8-K on 2026-02-18 disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on the officer or director change, including key position, appointment/resignation status, reasons, timing, board composition impact, or vote outcomes, are NOT_DISCLOSED. No quantitative metrics, financial data, scheduled events, or governance implications are explicitly stated.

• ·AccNo: 0001193125-26-057026
• ·Filing size: 324 KB
• ·Event date: 2026-02-18

18-02-2026

Lakeside Holding Ltd filed a Form 8-K on February 18, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. This appears to be a single-item filing with no additional details provided on the specific matters submitted, voting outcomes, share counts, or percentages. No financial metrics, positive or negative changes, or other quantitative data are disclosed.

18-02-2026

Grand Canyon Education, Inc. filed a Form 8-K on February 18, 2026, under Items 2.02 and 9.01, disclosing results of operations and financial condition along with financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned in the provided filing details. All quantitative financial metrics remain NOT_DISCLOSED.

18-02-2026

Mondelez International, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001628280-26-009018), reporting multiple material events under Item 1.01 (entry into a material definitive agreement), Item 1.02 (termination of a material definitive agreement), Item 2.03 (creation of a direct financial obligation or off-balance sheet arrangement), and Item 9.01 (financial statements and exhibits). No quantitative details such as transaction values, financial impacts, or period-over-period comparisons are disclosed. This multi-item filing indicates significant contractual changes, but lacks specifics on nature, size, or strategic implications.

18-02-2026

Armour Residential REIT, Inc. filed a Form 8-K on February 18, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of potentially material non-public information with attached exhibits. No financial metrics, transaction details, positive or negative changes, or other quantitative data are disclosed in the filing summary.

18-02-2026

Cue Biopharma, Inc. filed an 8-K on February 18, 2026, under Item 8.01 Other Events. No specific details, financial metrics, transactions, or comparisons are disclosed in the provided filing information.

18-02-2026

Phio Pharmaceuticals Corp. filed a Form 8-K on February 18, 2026 (AccNo: 0001437749-26-004542), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, timing details, or quantitative data such as compensation amounts are disclosed in the provided filing summary. Sector is not specified.

18-02-2026

Remitly Global, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits are included. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed.

18-02-2026

Brookdale Senior Living Inc. filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, margins, or other quantitative metrics are provided in the available information. No positive or negative performance indicators, guidance changes, or comparisons are detailed.

18-02-2026

YUNHONG GREEN CTI LTD. filed an 8-K on 2026-02-18 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names of individuals, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed. Sector information is not specified.

18-02-2026

Occidental Petroleum Corp filed an 8-K on February 18, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, or other quantitative financial metrics are detailed in the provided filing information. This appears to be a standard earnings-related disclosure with no period-over-period comparisons or guidance mentioned.

18-02-2026

Molson Coors Beverage Co filed an 8-K on 2026-02-18 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), indicating a voluntary disclosure of financial results. This multi-item filing provides an executive summary of financial performance but no specific revenue, earnings, or other metrics are explicitly stated in the provided filing description. No positive or negative performance indicators, guidance, or scheduled events are detailed.

18-02-2026

Bausch Health Companies Inc. filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached financial statements.

18-02-2026

Amplitude, Inc. filed an 8-K on February 18, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing details. This is a standard earnings-related disclosure with no quantitative data available for analysis.

18-02-2026

Medallion Financial Corp filed an 8-K on February 18, 2026 (AccNo: 0001193125-26-057046), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative financial metrics were disclosed in the provided filing information. The filing size is 749 KB, indicating potential attachments, but details are NOT_DISCLOSED.

• ·Filing size: 749 KB (suggests exhibits like earnings press release may be attached)
• ·Sector: not specified

18-02-2026

California BanCorp (CA) filed an 8-K on 2026-02-18 disclosing officer or director changes under Item 5.02, which covers departures, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific names, positions, reasons, financial metrics, or other quantitative details are disclosed.

18-02-2026

INTEGRATED BIOPHARMA INC filed an 8-K on 2026-02-18 reporting entry into a material definitive agreement under Item 1.01. Item 9.01 discloses financial statements and exhibits. No transaction details, financial metrics, positive or negative impacts, or other quantitative data are provided.

18-02-2026

Fortitude Gold Corp filed an 8-K on February 18, 2026, reporting under Item 3.02 Unregistered Sales of Equity Securities. No quantitative details such as transaction value, share count, or terms were disclosed. This is a single-item mandatory disclosure with no additional financial or operational metrics provided.

18-02-2026

Herbalife Ltd. filed an 8-K on February 18, 2026 (AccNo: 0001213900-26-017966), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period changes, or segment details are mentioned.

18-02-2026

ITT Inc. filed an 8-K on February 18, 2026 (AccNo: 0000216228-26-000018), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or other metrics are disclosed.

18-02-2026

M3-Brigade Acquisition V Corp. filed an 8-K on February 18, 2026, announcing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing includes financial statements and exhibits under Item 9.01. No specific transaction parties, deal terms, valuations, or financial metrics are disclosed.

18-02-2026

GD Culture Group Ltd filed an 8-K on February 18, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), marking a multi-item filing focused on voluntary public disclosure and attached exhibits. No financial metrics, transactions, revenue implications, or quantitative data are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period changes, or strategic events are mentioned.

18-02-2026

Sealed Air Corp/DE filed a Form 8-K on February 18, 2026 (AccNo: 0001193125-26-057312, size 188 KB) reporting under Item 8.01 Other Events. No specific details on the event, financial metrics, transactions, or impacts are disclosed in the provided filing summary. Sector is not specified, limiting assessment of materiality or implications.

18-02-2026

LanzaTech Global, Inc. filed an 8-K on 2026-02-18 (AccNo: 0001628280-26-009171, Size: 199 KB) disclosing under Item 1.01 entry into a Material Definitive Agreement. No details on the agreement's nature, parties, dollar value, financial impacts, or strategic context were provided. This appears to be a single-item mandatory filing with sector not specified.

18-02-2026

Chain Bridge I filed a Form 8-K on February 18, 2026 (AccNo: 0001213900-26-018000), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. This event indicates potential removal from US exchange listing with no additional financial metrics, impacts, or reasons disclosed. Sector not specified.

18-02-2026

Claros Mortgage Trust, Inc. filed an 8-K on February 18, 2026 (AccNo: 0001193125-26-057463), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are mentioned.

• ·Filing size: 17 MB
• ·Source: us_sec

18-02-2026

Trailblazer Merger Corp I filed an 8-K on 2026-02-18 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. Item 9.01 provides for financial statements and exhibits. No specific transaction parties, deal terms, valuations, financial metrics, or performance comparisons are disclosed in the provided filing information.

18-02-2026

Liminatus Pharma, Inc. filed a Form 8-K on February 18, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific details regarding the agreement, events, transaction value, financial impacts, or quantitative metrics are provided in the filing summary. This is a multi-item mandatory disclosure for Item 1.01 with potential voluntary elements in Item 8.01.

• ·Accession Number: 0001104659-26-017134
• ·Filing size: 942 KB
• ·Multi-item 8-K (Items 1.01, 8.01, 9.01)

18-02-2026

BROADWAY FINANCIAL CORP DE filed an 8-K on February 18, 2026, under Item 7.01 Regulation FD Disclosure. This is a voluntary disclosure to comply with Regulation Fair Disclosure requirements. No quantitative financial metrics, transactions, events, or performance comparisons are explicitly stated in the filing details provided.

18-02-2026

NewMarket Corp filed an 8-K on 2026-02-18 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, timing, or any quantitative data are disclosed. No positive or negative metrics, financial impacts, or governance implications are provided in the filing summary.

18-02-2026

SmartStop Self Storage REIT, Inc. filed a Form 8-K on 2026-02-18 reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No quantitative details such as transaction value, financial impacts, or specific terms are disclosed.